Search Results - "Osipenko, M F"

Refine Results
  1. 1

    Hemochromatosis - modern condition of the problem by Voloshinа, N B, Osipenko, M F, Litvinova, N V, Voloshin, A N

    Published in Terapevtic̆eskii arhiv (19-04-2018)
    “…The iron overload syndrome can be associated with various acquired states and hereditary factors. Hereditary hemochromatosis is the most common genetic…”
    Get full text
    Journal Article
  2. 2

    Successes and unsolved problems in the study of celiac disease by Osipenko, M F, Shrainer, E V, Parfenov, A I

    Published in Terapevtic̆eskii arhiv (01-01-2016)
    “…The review gives current views on the problem of celiac disease (gluten enteropathy). It presents the pathogenetic components of pathology development,…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Patient compliance as one of the factors determining the efficiency of eradication therapy by Osipenko, M F, Livzan, M A, Bikbulatova, E A

    Published in Terapevtic̆eskii arhiv (01-01-2014)
    “…To improve the quality of eradication therapy (ET), by increasing patient compliance. An open-label cohort multicenter randomized study was conducted. A total…”
    Get full text
    Journal Article
  5. 5

    The prevalence of bacterial overgrowth syndrome and its associated factors in patients with inflammatory bowel diseases (according to the data of the Novosibirsk registry) by Kulygina, Yu A, Osipenko, M F, Skalinskaya, M I, Pal'chunova, K D

    Published in Terapevtic̆eskii arhiv (01-01-2017)
    “…To assess the prevalence of bacterial overgrowth syndrome (BOS) and its risk factors in patients with inflammatory bowel diseases (IBD). The patients from the…”
    Get full text
    Journal Article
  6. 6

    Fecal calprotectin concentration in the differential diagnosis of bowel diseases by Osipenko, M F, Livzan, M A, Skalinskaya, M I, Lyalyukova, E A

    Published in Terapevtic̆eskii arhiv (01-01-2015)
    “…To estimate the informative value of a noninvasive fecal (calprotectin) test in the differential diagnosis of bowel diseases. One hundred and forty-two…”
    Get full text
    Journal Article
  7. 7

    Abdominal pain syndrome and quality of life in patients with cholelithiasis after cholecystectomy during a 10-year follow-up by Makarova, Yu V, Litvinova, N V, Osipenko, M F, Voloshina, N B

    Published in Terapevtic̆eskii arhiv (01-01-2017)
    “…To estimate the incidence of abdominal pain syndrome (APS) and to assess quality of life (QOL) in patients within 10 years after cholecystectomy (CE). This…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Clinical characteristics of dyspepsia in patients with diabetes mellitus type 2 by Osipenko, M F, Zhuk, E A, Medvedeva, O V

    Published in Terapevtic̆eskii arhiv (01-01-2013)
    “…To estimate the prevalence of dyspepsia and to study its clinical manifestations and risk factors in patients with type 2 diabetes mellitus. One hundred and…”
    Get full text
    Journal Article
  10. 10

    Fatty acid composition of blood serum and erythrocyte membranes in men with steatosis and steatohepatitis with normal transaminase activity by Kruchinina, M. V., Osipenko, M. F., Shestov, A. A., Parulikova, M. V.

    Published in Sechenovskiĭ vestnik (31-07-2024)
    “…Aim. To study the characteristics of the fatty acid (FA) profi le of blood serum and erythrocyte membranes in patients with two forms of fatty liver disease…”
    Get full text
    Journal Article
  11. 11

    Chronic acalculous cholecystitis and biliary dysfunction: how does clinical diagnosis affect management? by Kucheryavyy, Yu. A., Osipenko, M. F.

    Published in Medicinskij sovet (13-05-2021)
    “…Similar abdominal pain of biliary type in functional disorders of biliary tract and chronic acalculous cholecystitis causes objective difficulties to…”
    Get full text
    Journal Article
  12. 12

    Serum level of proteins involved in apoptosis and autophagy in patients with type 2 diabetes and non-alcoholic fatty liver disease by Krasner, Ya. A., Romanov, V. V., Fazullina, O. N., Osipenko, M. F., Klimontov, V. V.

    “…Aim of the study was to estimate the blood serum level of microtubule-associated protein 1 light chain 3 alpha (MAP1LC3alpha), beclin-1 (BECN-1), Bcl-2…”
    Get full text
    Journal Article
  13. 13

    Evaluation of the efficacy of prucalopride (resolor) in the treatment of patients with chronic constipation by Osipenko, M F, Bikbulatova, E A, Skalinskaia, M A, Kulygina, Iu A, Pankova, L Iu

    Published in Terapevtic̆eskii arhiv (01-01-2013)
    “…To evaluate the efficacy of the enterokinetic prucalopride (resolor) in patients with chronic constipation. The effect of treatment with prucalopride (resolor)…”
    Get full text
    Journal Article
  14. 14

    Serum biomarkers associated with liver fibrosis in patients with type 2 diabetes by Krasner, Y. A., Romanov, V. V., Fazullina, O. N., Osipenko, M. F., Klimontov, V. V.

    Published in Sakharnyĭ diabet (18-03-2024)
    “…BACKGROUND: The diagnosis of liver fibrosis is an important task in the management of patients with non-alcoholic fatty liver disease (NAFLD) and type 2…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Clinical features of different variants of excretory pancreatic insufficiency by Osipenko, M F, Venzhina, Iu Iu

    Published in Terapevtic̆eskii arhiv (01-01-2009)
    “…To analyse course of excretory pancreatic insufficiency (EPI) of pancreatic and not origin as well as factors associated with its development. A total of 139…”
    Get full text
    Journal Article
  17. 17

    Different characteristics of quality of life in celiac disease patients by Moiseenko, E E, Osipenko, M F, Ageeva, T A, Krotov, S A, Burbik, N N

    Published in Terapevtic̆eskii arhiv (01-01-2011)
    “…To study quality of life (QoL) in patients with celiac disease (CD) in the course of treatment with aglutenic diet (AD). Modern algorithm of glutenic…”
    Get full text
    Journal Article
  18. 18

    Fatty Acids of Erythrocyte Membranes and Blood Serum in Differential Diagnosis of Inflammatory Bowel Diseases by Kruchinina, M. V., Svetlova, I. O., Osipenko, M. F., Abaltusova, N. V., Gromov, A. A., Shashkov, M. V., Sokolova, A. S., Yakovina, I. N., Borisova, A. V.

    “…Aim: to study fatty acid levels in erythrocyte membranes (RBC) and blood serum (BS) in patients with inflammatory bowel diseases (IBDs) to develop differential…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Prevalence and characteristics of non-alcoholic steatohepatitis in patients with inflammatory bowel disease in the Novosibirsk region: a cross-sectional, one center study in 245 patients by Krasner, Ya. A., Kulygina, Yu. A., Valuyskikh, E. Yu, Osipenko, M. F.

    Published in Alʹmanakh klinicheskoĭ medit͡s︡iny (19-11-2018)
    “…Rationale: Recently, the incidence of inflammatory bowel disease (IBD) and non-alcoholic steatohepatosis has increased in developed countries. Also, there are…”
    Get full text
    Journal Article